Drug intelligence / Profile preview

Lactomix

Development stage: Unknown
Lead developer: Arosol Pharma
Administration: Oral

Overview

Lactomix is a veterinary herbal and nutritional supplement developed by Arosol Pharmaceuticals. It is designed for use in a wide range of animals, including livestock, poultry, pets, and aqua animals. Formulated based on Ayurvedic principles, Lactomix serves as a phytogenic feed additive intended to support animal health and nutritional requirements. It is marketed as a supportive product rather than a pharmaceutical drug with a specific molecular target, focusing on the synergistic effects of traditional herbal ingredients to improve the overall well-being and productivity of animals.

Brand names: Lactomix

Beyond the preview

Go deeper on Lactomix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lactomix.

Explore the full profile